FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2772990359> ?p ?o ?g. }

• W2772990359 endingPage "e0188899" @default.
• W2772990359 startingPage "e0188899" @default.
• W2772990359 abstract "Purpose To evaluate the safety and tolerability of intravitreal ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in patients with primary open angle glaucoma (POAG) undergoing trabeculectomy (TE; glaucoma filtration surgery). Methods In this prospective phase I trial glaucoma patients scheduled for TE with mitomycin C (MMC) received a single intravitreal injection of ISTH0036 at the end of surgery in escalating total doses of 6.75 μg, 22.5 μg, 67.5 μg or 225 μg, resulting in calculated intraocular ISTH0036 concentrations in the vitreous humor of approximately 0.3 μM, 1 μM, 3 μM or 10 μM after injection, respectively. Outcomes assessed included: type and frequency of adverse events (AEs), intraocular pressure (IOP), numbers of interventions post trabeculectomy, bleb survival, visual acuity, visual field, electroretinogram (ERG), slit lamp biomicroscopy and optic disc assessment. Results In total, 12 patients were treated in the 4 dose groups. Main ocular AEs observed were corneal erosion, corneal epithelium defect, or too high or too low IOP, among others. No AE was reported to be related to ISTH0036. All other safety-related analyses did not reveal any toxicities of concern, either. The mean medicated preoperative IOP at decision time-point for surgery was 27.3 mmHg +/- 12.6 mmHg (SD). Mean IOP (±SD) for dose levels 1, 2, 3, and 4 were at Day 43 9.8 mmHg ± 1.0 mmHg, 11.3 mmHg ± 6.7 mmHg, 5.5 mmHg ± 3.0 mmHg and 7.5 mmHg ± 2.3 mmHg SD; and at Day 85 9.7 mmHg ± 3.3 mmHg, 14.2 mmHg ± 6.5 mmHg, 5.8 mmHg ± 1.8 mmHg and 7.8 mmHg ± 0.6 mmHg, respectively. In contrast to IOP values for dose levels 1 and 2, IOP values for dose levels 3 and 4 persistently remained below 10 mmHg throughout the observation period. Conclusion This first-in-human trial demonstrates that intravitreal injection of ISTH0036 at the end of TE is safe. Regarding IOP control, single-dose ISTH0036 administration of 67.5 μg or 225 μg at the time of TE resulted in IOP values persistently < 10 mmHg over the three month postoperative observation period." @default.
• W2772990359 created "2017-12-22" @default.
• W2772990359 creator A5006576939 @default.
• W2772990359 creator A5006671688 @default.
• W2772990359 creator A5012518737 @default.
• W2772990359 creator A5013595483 @default.
• W2772990359 creator A5015670199 @default.
• W2772990359 creator A5021299894 @default.
• W2772990359 creator A5027653123 @default.
• W2772990359 creator A5032164477 @default.
• W2772990359 creator A5043310900 @default.
• W2772990359 creator A5057628788 @default.
• W2772990359 creator A5063141518 @default.
• W2772990359 creator A5063492070 @default.
• W2772990359 creator A5065695564 @default.
• W2772990359 creator A5074049671 @default.
• W2772990359 creator A5078431530 @default.
• W2772990359 creator A5079455074 @default.
• W2772990359 creator A5090700813 @default.
• W2772990359 date "2017-11-30" @default.
• W2772990359 modified "2023-10-12" @default.
• W2772990359 title "First-in-human phase I study of ISTH0036, an antisense oligonucleotide selectively targeting transforming growth factor beta 2 (TGF-β2), in subjects with open-angle glaucoma undergoing glaucoma filtration surgery" @default.
• W2772990359 cites W118667476 @default.
• W2772990359 cites W123239899 @default.
• W2772990359 cites W1274676424 @default.
• W2772990359 cites W1519762771 @default.
• W2772990359 cites W1606939947 @default.
• W2772990359 cites W1667265675 @default.
• W2772990359 cites W180387481 @default.
• W2772990359 cites W1805375919 @default.
• W2772990359 cites W1894989494 @default.
• W2772990359 cites W1941180110 @default.
• W2772990359 cites W1960434785 @default.
• W2772990359 cites W1980054286 @default.
• W2772990359 cites W1981015419 @default.
• W2772990359 cites W1996954680 @default.
• W2772990359 cites W2004655576 @default.
• W2772990359 cites W2006693614 @default.
• W2772990359 cites W2010538186 @default.
• W2772990359 cites W2011003854 @default.
• W2772990359 cites W2026886376 @default.
• W2772990359 cites W2027942320 @default.
• W2772990359 cites W2034742711 @default.
• W2772990359 cites W2037618281 @default.
• W2772990359 cites W2042831125 @default.
• W2772990359 cites W2044566561 @default.
• W2772990359 cites W2047894181 @default.
• W2772990359 cites W2052911528 @default.
• W2772990359 cites W2057266151 @default.
• W2772990359 cites W2061673720 @default.
• W2772990359 cites W2062907983 @default.
• W2772990359 cites W2071787763 @default.
• W2772990359 cites W2073537216 @default.
• W2772990359 cites W2076163951 @default.
• W2772990359 cites W2076188378 @default.
• W2772990359 cites W2081801020 @default.
• W2772990359 cites W2083398333 @default.
• W2772990359 cites W2088842983 @default.
• W2772990359 cites W2089432090 @default.
• W2772990359 cites W2115769066 @default.
• W2772990359 cites W2120952608 @default.
• W2772990359 cites W2136000087 @default.
• W2772990359 cites W2150361016 @default.
• W2772990359 cites W2268035988 @default.
• W2772990359 cites W2271869129 @default.
• W2772990359 cites W2291150585 @default.
• W2772990359 cites W2319397046 @default.
• W2772990359 cites W2412930035 @default.
• W2772990359 cites W2588900147 @default.
• W2772990359 cites W4368144049 @default.
• W2772990359 cites W777727261 @default.
• W2772990359 doi "https://doi.org/10.1371/journal.pone.0188899" @default.
• W2772990359 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5708654" @default.
• W2772990359 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29190672" @default.
• W2772990359 hasPublicationYear "2017" @default.
• W2772990359 type Work @default.
• W2772990359 sameAs 2772990359 @default.
• W2772990359 citedByCount "48" @default.
• W2772990359 countsByYear W27729903592017 @default.
• W2772990359 countsByYear W27729903592018 @default.
• W2772990359 countsByYear W27729903592019 @default.
• W2772990359 countsByYear W27729903592020 @default.
• W2772990359 countsByYear W27729903592021 @default.
• W2772990359 countsByYear W27729903592022 @default.
• W2772990359 countsByYear W27729903592023 @default.
• W2772990359 crossrefType "journal-article" @default.
• W2772990359 hasAuthorship W2772990359A5006576939 @default.
• W2772990359 hasAuthorship W2772990359A5006671688 @default.
• W2772990359 hasAuthorship W2772990359A5012518737 @default.
• W2772990359 hasAuthorship W2772990359A5013595483 @default.
• W2772990359 hasAuthorship W2772990359A5015670199 @default.
• W2772990359 hasAuthorship W2772990359A5021299894 @default.
• W2772990359 hasAuthorship W2772990359A5027653123 @default.
• W2772990359 hasAuthorship W2772990359A5032164477 @default.
• W2772990359 hasAuthorship W2772990359A5043310900 @default.
• W2772990359 hasAuthorship W2772990359A5057628788 @default.
• W2772990359 hasAuthorship W2772990359A5063141518 @default.
• W2772990359 hasAuthorship W2772990359A5063492070 @default.

• next